Showing results (971-980 of 2,283) with videos related to
Sort By:
Pageof 229
HIV Medicine|April 16, 2008
Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European regionJ V Lazarus, M Olsen, L Ditiu, et al.HIV Medicine|July 2, 2008
To test or not to test: psychosocial barriers to HIV testing in high-income countriesJ B F de Wit, P C G AdamHIV Medicine|July 2, 2008
Barriers to HIV testing for migrant black Africans in Western EuropeI Fakoya, R Reynolds, G Caswell, et al.HIV Medicine|June 19, 2008
RNA amplification of the HIV-1 Pol and env regions on dried serum and plasma spotsR Dachraoui, D Brand, S Brunet, et al.HIV Medicine|January 29, 2021
Modelling the impact of an HIV testing intervention on HIV transmission among men who have sex with men in ChinaRoss D Booton, Jason J Ong, Amy Lee, et al.HIV Medicine|February 2, 2021
Trends and predictors of linkage to HIV outpatient care following diagnosis in the era of expanded testing in England, Wales and Northern Ireland: Results of a national cohort studyS Croxford, F Burns, A Copas, et al.HIV Medicine|February 2, 2021
Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidenceY S Punekar, D Parks, M Joshi, et al.HIV Medicine|December 22, 2016
An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profileP Kumar, Y S Lakshmi, A K KondapiHIV Medicine|April 23, 2014
HIV Tat protein affects circadian rhythmicity by interfering with the circadian systemT Wang, Z Jiang, W Hou, et al.HIV Medicine|March 2, 2019
Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?S Moreno, C F Perno, P W Mallon, et al.Pageof 229